查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933340

全球心臟PET（正子斷層掃描）市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Cardiology Positron Emission Tomography Scan Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 請詢問到貨日

價格

心臟PET（正子斷層掃描）市場成長因素

預計全球心臟PET（正子斷層掃描）市場規模在2025年將達到19.3億美元，2026年將成長至19.8億美元，到2034年將達到28.3億美元，預測期內複合年增長率（CAGR）為4.55%。心臟PET是一種非侵入性影像技術，它使用放射性示蹤劑來評估心臟代謝、心肌灌注、發炎和活力。這些檢查對於診斷冠狀動脈疾病 (CAD)、評估心肌梗塞後的心臟損傷以及製定諸如搭橋手術等外科手術方案至關重要。

到 2025 年，北美將以 10.73% 的市場佔有率引領市場，這主要得益於心臟病患病率的上升、先進的醫療基礎設施以及診斷成像系統技術的持續創新。主要參與者包括 Sonic Healthcare Limited、Apex Radiology、Alliance Medical 和 Siemens Healthineers Limited，它們均透過有機成長和無機成長相結合的方式在全球擴張。

市場動態

驅動因素：PET 掃描儀和放射性藥物的技術進步是主要驅動因素。西門子醫療等公司推出了 Biograph Trinion PET/CT 掃描儀等先進系統，這些系統提供人工智慧驅動的工作流程和整合式患者監護功能，以提高診斷準確性和患者舒適度。心血管疾病盛行率不斷上升、人口老化以及對非侵入性診斷方法的偏好進一步推動了市場成長。

限制因素：PET/CT 系統的高昂成本（22.5 萬美元至 75 萬美元）以及熟練的核子醫學專業人員短缺是重要的障礙。貿易保護主義，包括新興市場的關稅和監管要求，可能會進一步延緩技術的普及並增加成本。

機會：對能夠加快工作流程的先進診斷影像系統的需求不斷增長，帶來了巨大的機會。 IONETIX 和 Provision Diagnostic Imaging 等全球和本地公司之間的合作旨在開發能夠更快獲得檢測結果的先進診斷成像流程。

挑戰：短壽命放射性示蹤劑的供應有限，尤其是那些需要現場迴旋加速器的示蹤劑，限制了市場成長。供應鏈中斷、監管檢查和維護停機可能會延遲診斷程序並降低系統可用性。

市場趨勢

市場正向混合影像系統（例如 PET/CT 和 PET/MRI）轉型，這些系統可提供更優異的功能和解剖解析度。這些系統能夠改善心肌灌注和冠狀動脈血流儲備的評估。此外，人工智慧和軟體的整合正在提高心臟成像的診斷準確性和操作效率。

細分市場分析

依資金來源劃分：由於能夠獲得更多個人化醫療服務和多樣化的服務提供者，私人醫療保險/自費市場佔主導地位。由於報銷政策不足，公共保險市場的成長預計將會放緩，但諸如 2025 年 CMS 提案等政策改革正在擴大 PET/CT 檢查的覆蓋範圍。

依服務提供者劃分：醫院憑藉其先進的設施、訓練有素的人員以及處理複雜心臟手術的能力，佔了最大的市場佔有率。由於等待時間縮短、成本效益提高以及與影像技術供應商合作增多，診斷中心預計將以最高的複合年增長率增長。其他服務提供者，例如研究機構和心臟中心，由於患者偏好有限，增長較為緩慢。

區域展望

  • 北美：預計到2026年，該市場規模將達到11.3億美元，主要受冠狀動脈疾病高發生率和對先進診斷工具投資的推動。美國和加拿大憑藉其強大的醫療保健基礎設施和精準診斷技術的應用，處於領先地位。
  • 歐洲：該地區繼續保持顯著的市場佔有率，主要得益於技術應用和旨在提高診斷效率的合作舉措。英國為診斷數位化投入3.34億美元等投資，正在推動該地區的成長。
  • 亞太地區：預計該地區將實現最高的複合年增長率，主要受意識提高、政府投資以及中國和日本等國在放射性藥物生產方面開展的合作的推動。 拉丁美洲：成長主要受心血管疾病盛行率上升和對先進診斷技術投資的推動。 中東和非洲：由於醫療保健支出增加、可支配收入成長以及政府主導的先進心臟影像診斷技術發展計劃，預計將保持穩定成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要產業趨勢：併購、業務合作等
  • 主要國家心臟病盛行率（2025 年）
  • 新產品發布
  • 主要參與者的關鍵產業趨勢

第五章 全球心臟 PET（正子斷層掃描）市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依資金來源劃分
    • 公共醫療保險
    • 私人醫療保險/自費
  • 市場分析、洞察與預測：依服務提供者劃分
    • 醫院
    • 診斷中心
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美心臟PET（正子斷層掃描）市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 美國
    • 加拿大

第七章：歐洲心臟PET（正子斷層掃描）市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章：亞太地區心臟PET（正子斷層掃描）市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞亞洲
    • 亞太其他地區

第九章：拉丁美洲心臟PET（正子斷層掃描）市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲心臟PET（正子斷層掃描）市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）國家
    • 南非
    • 中東和非洲其他地區

第十一章 競爭格局分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • RadNet, Inc.
    • Sonic Healthcare Limited
    • Akumin Inc.
    • Apex Radiology
    • Alliance Medical Limited
    • Novant Health
    • InHealth Group
    • Dignity Health
    • Concord Medical
    • Siemens Healthcare Limited
    • Mediworks
    • 其他主要參與者
Product Code: FBI113310

Growth Factors of cardiology positron emission tomography (PET) scan Market

The global cardiology positron emission tomography (PET) scan market was valued at USD 1.93 billion in 2025 and is projected to grow to USD 1.98 billion in 2026, reaching USD 2.83 billion by 2034, registering a CAGR of 4.55% during the forecast period. Cardiac PET is a non-invasive imaging procedure that uses radioactive tracers to evaluate heart metabolism, myocardial perfusion, inflammation, and viability. These scans are critical for diagnosing coronary artery disease (CAD), evaluating heart damage post-heart attack, and planning surgical procedures such as bypass surgeries.

North America dominated the market in 2025 with a 10.73% share, driven by the rising prevalence of cardiac conditions, advanced healthcare infrastructure, and continual technological advancements in imaging systems. Key players in the market include Sonic Healthcare Limited, Apex Radiology, Alliance Medical, and Siemens Healthcare Limited, which are adopting both organic and inorganic strategies to expand globally.

Market Dynamics

Drivers: Technological advancements in PET scanners and radiopharmaceuticals are primary drivers. Companies such as Siemens Healthineers have launched advanced systems like the Biograph Trinion PET/CT scanner, offering AI-powered workflow and integrated patient monitoring, improving diagnostic accuracy and patient comfort. The growing prevalence of cardiovascular diseases, aging population, and preference for non-invasive diagnostics further propel market growth.

Restraints: The high cost of PET/CT systems, ranging from USD 225,000 to USD 750,000, and the shortage of skilled nuclear medicine professionals are significant barriers. Trade protectionism, including tariffs and regulatory requirements in emerging markets, can further delay adoption and increase costs.

Opportunities: Rising demand for advanced imaging systems with faster workflows presents a substantial opportunity. Collaborations between global and local companies, such as IONETIX and Provision Diagnostic Imaging, aim to develop advanced imaging procedures with shorter turnaround times.

Challenges: Limited availability of radiotracers, especially those requiring on-site cyclotrons due to short half-lives, constrains market growth. Supply chain disruptions, regulatory inspections, and maintenance downtimes can delay diagnostic procedures and reduce system utilization.

Market Trends

The market is witnessing a shift toward hybrid imaging systems, such as PET/CT and PET/MRI, which provide superior functional and anatomical resolution. These systems improve assessment of myocardial perfusion and coronary flow reserve. Additionally, AI and software integrations are enhancing diagnostic precision and operational efficiency in cardiac imaging.

Segmentation Analysis

By Source of Payment: The private health insurance/out-of-pocket segment dominates due to better access to personalized treatment and a wider range of service providers. The public insurance segment is expected to grow slowly, limited by insufficient reimbursement policies, though policy reforms such as the 2025 CMS proposal aim to enhance coverage for PET/CT procedures.

By Service Provider: Hospitals retain the largest share due to advanced facilities, trained personnel, and capability to handle complex cardiac procedures. Diagnostic centers are projected to grow at the fastest CAGR because of shorter waiting times, cost-effectiveness, and increasing collaborations with imaging technology providers. Other service providers, such as research institutes and cardiac centers, exhibit stagnant growth due to limited patient preference.

Regional Outlook

  • North America: Market value stood at USD 1.13 billion in 2026, driven by high CAD prevalence and investments in advanced diagnostic tools. The U.S. and Canada are leading due to robust healthcare infrastructure and adoption of precision diagnostics.
  • Europe: Maintains a significant share due to technological adoption and collaborative initiatives for improving diagnostic efficiency. Investments, such as the UK's USD 334 million allocation for diagnostic digitalization, support growth.
  • Asia Pacific: Expected to register the highest CAGR, fueled by rising awareness, government investments, and partnerships for radiopharmaceutical production in countries like China and Japan.
  • Latin America: Growth driven by increasing cardiovascular disease prevalence and investments in advanced diagnostics.
  • Middle East & Africa: Steady growth due to rising healthcare spending, disposable incomes, and government initiatives for advanced cardiac imaging.

Competitive Landscape

The market is fragmented yet dominated by key players including Sonic Healthcare Limited, Apex Radiology, Siemens Healthcare Limited, and Novant Health, who focus on innovation, strategic partnerships, and distribution expansion. Notable developments include Positron Corporation's PET/CT rental program (2024) and Siemens Healthcare's high-performance PET/CT scanner launch (2024), enhancing operational efficiency and diagnostic precision.

Conclusion

The global cardiology PET scan market is poised for steady growth, from USD 1.93 billion in 2025 to USD 2.83 billion by 2034, driven by technological innovations, rising cardiac disease prevalence, and increasing demand for non-invasive, high-resolution imaging. North America maintains dominance, while Asia Pacific offers the highest growth potential due to increased awareness and investments. Despite challenges like high equipment costs, skilled workforce shortage, and radiotracer availability, the adoption of hybrid imaging systems, AI integration, and private insurance-driven healthcare solutions are expected to sustain market expansion. Leading players focusing on innovation and partnerships will shape the competitive landscape in the coming years.

Segmentation By Source of Payment

  • Public
  • Private Health Insurance/Out-of-pocket

By Service Provider

  • Hospitals
  • Diagnostic Centers
  • Others

By Geography

  • North America (By Source of Payment, Service Provider, and Country)
    • U.S.
    • Canada
  • Europe (By Source of Payment, Service Provider, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Source of Payment, Service Provider, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Source of Payment, Service Provider, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Source of Payment, Service Provider, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Recent Industry Developments such as Partnerships, Mergers, and Acquisitions
  • 4.2. Prevalence of Cardiac Conditions, Key Countries, 2025
  • 4.3. New Product Launches
  • 4.4. Key Industry Developments, Key Players

5. Global Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 5.1.1. Public
    • 5.1.2. Private Health Insurance/Out-of-pocket
  • 5.2. Market Analysis, Insights and Forecast - By Service Providers
    • 5.2.1. Hospitals
    • 5.2.2. Diagnostic Centers
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 6.1.1. Public
    • 6.1.2. Private Health Insurance/Out-of-pocket
  • 6.2. Market Analysis, Insights and Forecast - By Service Providers
    • 6.2.1. Hospitals
    • 6.2.2. Diagnostic Centers
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 7.1.1. Public
    • 7.1.2. Private Health Insurance/Out-of-pocket
  • 7.2. Market Analysis, Insights and Forecast - By Service Providers
    • 7.2.1. Hospitals
    • 7.2.2. Diagnostic Centers
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia pacific Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 8.1.1. Public
    • 8.1.2. Private Health Insurance/Out-of-pocket
  • 8.2. Market Analysis, Insights and Forecast - By Service Providers
    • 8.2.1. Hospitals
    • 8.2.2. Diagnostic Centers
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 9.1.1. Public
    • 9.1.2. Private Health Insurance/Out-of-pocket
  • 9.2. Market Analysis, Insights and Forecast - By Service Providers
    • 9.2.1. Hospitals
    • 9.2.2. Diagnostic Centers
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Source of Payment
    • 10.1.1. Public
    • 10.1.2. Private Health Insurance/Out-of-pocket
  • 10.2. Market Analysis, Insights and Forecast - By Service Providers
    • 10.2.1. Hospitals
    • 10.2.2. Diagnostic Centers
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. RadNet, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Sonic Healthcare Limited
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Akumin Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Apex Radiology
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Alliance Medical Limited
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Novant Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. InHealth Group
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Dignity Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Concord Medical
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Siemens Healthcare Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Mediworks
      • 11.2.11.1. Overview
      • 11.2.11.2. Products
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. Other Prominent Players
      • 11.2.12.1. Overview
      • 11.2.12.2. Products
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 2: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 3: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 5: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 6: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 8: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 9: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 11: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 12: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 14: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 15: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
  • Table 17: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
  • Table 18: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Cardiology Positron Emission Tomography Scan Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025 & 2034
  • Figure 3: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025 & 2034
  • Figure 4: Global Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 6: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 7: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 8: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 9: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country, 2025
  • Figure 11: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 12: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 13: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 14: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 15: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 18: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 19: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 20: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 21: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 24: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 25: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 26: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 27: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
  • Figure 30: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
  • Figure 31: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
  • Figure 32: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
  • Figure 33: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Cardiology Positron Emission Tomography Scan Market Share (%), By Company, 2025